Stock Track | Maravai LifeSciences Plunges 5.24% Pre-market as Earnings Release Delayed, Revenue Recognition Issues

Stock Track

02-25

Maravai LifeSciences Holdings, Inc. (MRVI) stock plunged 5.24% in pre-market trading on Tuesday, as the company announced the postponement of its Q4 2024 earnings release and a delay in filing its annual report (Form 10-K) for the year ended December 31, 2024.

The life sciences company cited several reasons for the delay, including the need for additional time to assess a potential non-cash impairment charge related to goodwill from a previous acquisition, and an error in revenue recognition that resulted in $3.9 million being recorded in the wrong quarter (Q2 2024 instead of Q3 2024).

MRVI also noted that it requires more time to complete its assessment of the effectiveness of its internal controls over financial reporting, including the remediation of a material weakness in controls over revenue recognition identified by management.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/1134711971"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1134711971\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/1134711971?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-02-25 19:06","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1134711971","market":"hk","top_or_hot":-1,"title":"Stock Track | Maravai LifeSciences Plunges 5.24% Pre-market as Earnings Release Delayed, Revenue Recognition Issues","media":"Stock Track","content":"<p>Maravai LifeSciences Holdings, Inc. (MRVI) stock plunged 5.24% in pre-market trading on Tuesday, as the company announced the postponement of its Q4 2024 earnings release and a delay in filing its annual report (Form 10-K) for the year ended December 31, 2024.</p>\n\n<p>The life sciences company cited several reasons for the delay, including the need for additional time to assess a potential non-cash impairment charge related to goodwill from a previous acquisition, and an error in revenue recognition that resulted in $3.9 million being recorded in the wrong quarter (Q2 2024 instead of Q3 2024).</p>\n\n<p>MRVI also noted that it requires more time to complete its assessment of the effectiveness of its internal controls over financial reporting, including the remediation of a material weakness in controls over revenue recognition identified by management.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Maravai LifeSciences Plunges 5.24% Pre-market as Earnings Release Delayed, Revenue Recognition Issues</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Maravai LifeSciences Plunges 5.24% Pre-market as Earnings Release Delayed, Revenue Recognition Issues\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2025-02-25 19:06</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Maravai LifeSciences Holdings, Inc. (MRVI) stock plunged 5.24% in pre-market trading on Tuesday, as the company announced the postponement of its Q4 2024 earnings release and a delay in filing its annual report (Form 10-K) for the year ended December 31, 2024.</p>\n\n<p>The life sciences company cited several reasons for the delay, including the need for additional time to assess a potential non-cash impairment charge related to goodwill from a previous acquisition, and an error in revenue recognition that resulted in $3.9 million being recorded in the wrong quarter (Q2 2024 instead of Q3 2024).</p>\n\n<p>MRVI also noted that it requires more time to complete its assessment of the effectiveness of its internal controls over financial reporting, including the remediation of a material weakness in controls over revenue recognition identified by management.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"MRVI","symbol_name":"Maravai LifeSciences Holdings, Inc.","start_time":0,"source_url":"","article_id":"1134711971","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1134711971","pubTimestamp":1740481589,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Maravai LifeSciences Holdings, Inc.  stock plunged 5.24% in pre-market trading on Tuesday, as the company announced the postponement of its Q4 2024 earnings release and a delay in filing its annual report  for the year ended December 31, 2024.The life sciences company cited several reasons for the delay, including the need for additional time to assess a potential non-cash impairment charge related to goodwill from a previous acquisition, and an error in revenue recognition that resulted in $3.9","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"MRVI":"Maravai LifeSciences Holdings, Inc."},"translate_title":"由于财报发布延迟、收入确认问题，Maravai LifeSciences盘前暴跌5.24%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"MRVI":1},"content_text":"Maravai LifeSciences Holdings, Inc. (MRVI) stock plunged 5.24% in pre-market trading on Tuesday, as the company announced the postponement of its Q4 2024 earnings release and a delay in filing its annual report (Form 10-K) for the year ended December 31, 2024.\nThe life sciences company cited several reasons for the delay, including the need for additional time to assess a potential non-cash impairment charge related to goodwill from a previous acquisition, and an error in revenue recognition that resulted in $3.9 million being recorded in the wrong quarter (Q2 2024 instead of Q3 2024).\nMRVI also noted that it requires more time to complete its assessment of the effectiveness of its internal controls over financial reporting, including the remediation of a material weakness in controls over revenue recognition identified by management.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"code":"91000000","status":"200"}}}